← Leaderboards
Robert John Kerns
University Of Iowa
$3,853,107
Attributed
$4,874,832
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $771.1K · FY2006–21$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,874,832 · 4
By mechanism
R01$3,394,767 · 2
T32$1,116,662 · 1
R21$363,403 · 1
Top collaborators
- Karl A Drlica5 shared
- Xilin Zhao5 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Thomas Edward Prisinzano$12,863,686
- Michael King Schultz$1,036,668
- Stephen J Reynolds$26,016,540
- Robert Paul Hoffman$1,221,396
- Bradley E Britigan$1,998,094
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceMycobacterialCellsMycobacterium TuberculosisMolecular ModelingMutantDesignDna TopoisomerasesGrowthInfectionKillingsLeadAntibioticsMolecular ModelsDrug ResistanceComplexDna GyraseBinding (Molecular Function)BiochemicalBiochemistryEscherichia ColiFluoroquinolonesInhibitor/AntagonistOrganism
Grant awards (17)
Predoctoral Training Program in Biotechnology$213,009
T32 · FY2021 · GM · contact PI
Predoctoral Training Program in Biotechnology$230,734
T32 · FY2020 · GM · contact PI
Predoctoral Training Program in Biotechnology$227,468
T32 · FY2019 · GM · contact PI
Predoctoral Training Program in Biotechnology$224,281
T32 · FY2018 · GM · contact PI
Predoctoral Training Program in Biotechnology$221,170
T32 · FY2017 · GM · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$385,234
R01 · FY2015 · AI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$385,234
R01 · FY2014 · AI
Antibacterial Agents that Restrict the Emergence of Resistance$370,867
R01 · FY2014 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$362,120
R01 · FY2013 · AI
Antibacterial Agents that Restrict the Emergence of Resistance$348,735
R01 · FY2013 · AI · contact PI
Antibacterial Agents that Restrict the Emergence of Resistance$371,114
R01 · FY2012 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$326,758
R01 · FY2012 · AI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$73,242
R01 · FY2012 · AI
Antibacterial Agents that Restrict the Emergence of Resistance$371,228
R01 · FY2011 · AI · contact PI
Antibacterial Agents that Restrict the Emergence of Resistance$400,235
R01 · FY2010 · AI · contact PI
Saccharide-Based Effectors of Cationic Antimicrobial Peptides$179,028
R21 · FY2007 · AI · contact PI
Saccharide-Based Effectors of Cationic Antimicrobial Peptides$184,375
R21 · FY2006 · AI · contact PI